2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC
Announces Pricing of $20 Million Registered Direct Offering of Common Stock
Investor Presentation
Humacyte Enters $60 Million Sales Agreement with TD Cowen
Termination of Revenue Interest Purchase Agreement - Humacyte, Inc. Pays $38M
Humacyte Enters $77.5 Million Loan Agreement with Avenue Venture
Termination of Open Market Sale Agreement with Jefferies LLC
Announces Third Quarter 2025 Financial Results and Provides Business Update
Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering
FY 2025
Q3
Q2
Q1
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload